Sterling Wealth Management’s AbbVie ABBV Stock Holding History

Sterling Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$660K	Buy	3,033 +2	+0.1%	+$444	0.18%	52
2025 Q4	$693K	Buy	3,031 +149	+5%	+$33.9K	0.2%	50
2025 Q3	$667K	Buy	2,882 +2	+0.1%	+$407	0.2%	52
2025 Q2	$535K	Buy	+2,880	New	+$535K	0.18%	55
2024 Q4	$527K	Buy	2,967 +1	+0%	+$184	0.19%	57
2024 Q3	$586K	Buy	2,966 +2	+0.1%	+$373	0.22%	56
2024 Q2	$508K	Buy	2,964 +114	+4%	+$18.9K	0.24%	54
2024 Q1	$519K	Buy	2,850 +2	+0.1%	+$345	0.26%	51
2023 Q4	$441K	Buy	+2,848	New	+$415K	0.25%	56

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sterling Wealth Management's ABBV Position: Q1 2026 in Review

Sterling Wealth Management increased its AbbVie (ABBV) stake by 0.07% in Q1 2026, buying an estimated $444 and bringing the position to 3,033 shares worth $660K. The position accounts for 0.18% of the portfolio, ranked #52.

Sterling Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 9 quarters since. The position peaked at $693K in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Sterling Wealth Management held 3,033 shares of AbbVie worth $660K as of Q1 2026.
Sterling Wealth Management bought 2 AbbVie shares in Q1 2026, an estimated $444.
AbbVie made up 0.18% of Sterling Wealth Management's portfolio in Q1 2026, its #52 holding.
Sterling Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 9 quarters since.
Sterling Wealth Management's AbbVie position peaked at $693K in Q4 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Sterling Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.